Tag Archives: healthcare

Tales from the Road – Arab Health

We’ve just departed from Dubai having completed a very successful Arab Health exposition. The Vasomedical booth included displays, graphics and demonstrations from all segments of our company profile, including EECP® and ECP therapy systems, Biox’ new ECG Holter and ambulatory blood pressure monitors and our wireless MobiCare™ patient monitoring products. Our booth location was ideal, we were in one of the convention center’s main concourses and was extremely busy throughout the whole show. We were joined in the booth by our associates from Biox and VSK, Vasomedical’s newest joint venture for marketing and sales of EECP/ECP technology globally. Together we welcomed many visitors from all over the Middle East, as well as visitors from North America, Europe and India.

This show allowed us to increase our exposure in the Middle East. There are treatment centers in the Kingdom of Saudi Arabia, the United Arab Emirates, Egypt, Jordan, the Sudan, Bahrain, Oman and Israel. Many physicians in the region are familiar with the clinical benefits of the therapy and are very interested in bringing the technology to their local hospitals and clinics.

Biox – MobiCare™ wireless patient monitoring products attracted a high level of interest at the show. The flexibility to un-tether the patient from the monitor using Bluetooth technology is very unique. Along with the added feature of remote viewing capabilities away from the clinical setting by physicians, healthcare workers and patient families, it was evident that MobiCare™ was one of the most interesting new products seen by many of the attendees.

Tales From the Road: Medical Fair Asia 2014

As Medical Fair Asia comes to a close in Singapore on Sept 11th, 2014, many of us are reflecting on this day. 13 years ago millions of people went to sleep not knowing the world was about to change forever. We continue to think about the people we lost that day and will keep them and their families in our thoughts, our hearts and our prayers.

Medical Fair Asia has been another successful meeting. There were constant visitors to our booth, they came from all over Southeast Asia to participate in this show, which is one of the largest medical industry conferences in the Asian market.  Hospital and healthcare administrators, physicians and many distributors came to our booth wanting to see our products; they were especially interested in MobiCare®, a unique wireless patient monitoring system with flexible communications capabilities.

MobiCare frees the patients from typical bedside monitoring and allows them the freedom to move about the room and nearby areas with comfort and safety. In addition, the ability to perform remote viewing functions by authorized personnel expanded the potential capabilities to meet multiple needs of a quickly growing and more challenging healthcare marketplace. The need for safe and reliable monitoring for patients is no longer limited to bedside monitoring in the hospital, nor does it stop when the patient is discharged. There is a rapidly growing need to provide better medical services in some of the most unique situations and MobiCare’s communication flexibility meets that monitoring challenge head on.

Though there have been a few scattered EECP Therapy systems throughout the region, EECP Therapy is not generally well known in Southeast Asia. Some of our distributors visited us to discuss opportunities and projects they are currently working on and plans to expand awareness in their designated territories. While most healthcare professionals in the region are not aware of the therapy, our participation in international shows expands awareness of the therapy and is creating a bigger audience for its acceptance. Many new distributors visited our booth and expressed interest in becoming our authorized representative in their respective countries for EECP Therapy, as well as our Biox ECG Holter and ambulatory monitoring products.

We also had an opportunity to learn more about the regulatory and typical marketing practices in many of the countries represented here. Having a better understanding and establishing connections in this region will help us ensure we approach the markets in the best way possible to create opportunities to generate revenue, while controlling and monitoring expenses.

Make sure to stay tuned for more tales from the road as we continue to showcase and educate the healthcare industry about EECP Therapy technology and our other offerings.

Tales From the Road – European Society of Cardiology (ESC) in Barcelona

The last three and a half days exhibiting and demonstrating our EECP® Therapy and Biox products at the European Society of Cardiology (ESC) in Barcelona were extremely busy, slightly challenging at times, and very, very rewarding. Attendee traffic at our booth was very good due to a number of factors but especially the pre-show preparation which included setting up key meeting with prospective customers and mailing invitations to distributors, physicians, hospital and government personnel to visit our booth. Visitors enjoyed the opportunity to learn about our company, our products and how we can help them meet the challenges of providing more cost-effective healthcare to a rapidly growing and aging patient population in their respective countries.

Bolstered by the inclusion, for the first time, of EECP® Therapy in the ESC guidelines on the management of stable coronary artery disease with a IIa class recommendation, we received a significant amount of new and renewed interest in EECP® Therapy. In the addenda to the writing committees, after they had reviewed the large volume of clinical literature regarding EECP® Therapy, stated, “The results of these studies proving the concept and clinical effects of EECP treatment lead to the recommendation that EECP Therapy should be considered for symptomatic treatment in patients with invalidating refractory angina.”

In addition, a poster, entitled the “Long-term clinical outcomes in patients with coronary artery disease and moderate angina pectoris treated with enhanced external counterpulsation” by Dr. Ozlem Soran, et al, from the University of Pittsburgh Medical, Pittsburg, PA, was presented in this year’s ESC annual meeting. In the abstract, the authors summarized the clinical benefits by stating that “Patients presenting for EECP treatment with class II angina had different baseline profiles compared with Class III and IV angina. However, both cohorts achieved substantial reduction in angina with high event free survival rates at 2 years.”

There was considerable interest shown by both cardiologists as well as the administrators of hospitals, clinics and private physician practices in the company’s latest offering, the MobiCare™ wireless vital signs patient monitor. The comprehensive monitoring features and the unique communications capabilities of MobiCare™ provide clinician with accurate patient information and optimal flexibility to view the patient’s vital signs remotely on a tablet or smart phone.

Supported by our colleagues from Biox as well as personnel from our European and Korean distributors, the exhibition booth, though very busy at times, was well covered and it soon became customary to hear at least three or four foreign languages spoken in the booth simultaneously.

During the exhibition we closed multiple sales deals, including the sale of the Lumenair™ EECP® Therapy system used for live demonstrations in the show right out of the booth.

Exercise and heart health– Can there be too much of a good thing?

We’ve all heard that exercising keeps the heart healthy – whether it’s a run, yoga class or cycling. But how much exercise is healthy and can too much be harmful?

According to a recent piece by MedPage Today, “too much of a good thing” can become a reality, and one must be tuned in to his or her limits.  It looks like moderate exercise may be the way to go, even for healthy patients.

The article states:

“Research involving stable chronic heart disease (CHD) patients found daily strenuous exercise to be associated with a more than twofold increased risk for cardiovascular mortality compared with moderate (two- to four-times a week) exercise (2.36, 95% CI 1.05-5.34).”

This is not an excuse to skip your exercise though! Researchers found that moderate, regular exercise is important for maintaining a healthy heart. Widely accepted guidelines recommend 30-60 minutes of moderate intensity aerobic activity five to seven days per week.

You can read the full piece here: http://www.medpagetoday.com/Cardiology/Prevention/45785

Tell us – how much exercise do you get each week? What’s your favorite form of cardio?  Email us with your heart-healthy exercises at vaso@kcsa.com.

Patient Spotlight: EECP Therapy is Treatment of Choice for Rev. Michael Bernard Beckwith

Reverend Beckwith, the founder and spiritual director of Agape International Spiritual Center in Los Angeles, has been visiting Global Cardio Care for about eight years and is a huge advocate for EECP Therapy.

The Reverend has been receiving EECP Therapy since 2004 as a preventative treatment to ensure his system is functioning to its best capacity and he has optimal blood flow. Due to a hectic schedule which includes a great deal of travel and public speaking, he believes maintaining his system and focusing on his circulation and healthy diet are critical.

According to Rev. Beckwith:

“It is essential, if someone is going to do their life work, if someone’s going to release their gifts, their talents, their capacities – which is what I teach – they need to be healthy. It’s a sad thing to see someone who has a great dream within their heart and soul but can’t manifest it because they’re sick all the time.”

In the video, the Reverend discusses not only his excellent experience with EECP Therapy, but relays the positive experiences of several members of his congregation as well.

 

You can view the full video here: https://www.youtube.com/watch?v=CewwGQD–DA&feature=youtu.be

 

Indian State Expands Access to EECP® Therapy for Patients

Through a program known as Public Private Partnership (PPP), the government of the state of Tamil Nadu in India, in cooperation with VasoMeditech Ltd., Vasomedical’s authorized distributor in India, has launched the Non-Invasive Ischemic Burden Reduction Program (NIBP-P) to bring EECP® Therapy to patients seeking treatment for their coronary artery disease in the government medical college hospitals in the region.

This new program aims to tackle the growing epidemic of cardiovascular disease in India and help the government handle the increase in the number of patients seeking treatment in the public hospital sector. The project includes a continuing medical education program launched by VasoMeditech in collaboration with Madras Medical College on non-invasive options for patients with recurrent angina and heart failure emphasizing the clinical benefits and use of EECP Therapy.

EECP® treatment is currently available through this program at Rajiv Gandhi Government Medical College Hospital, Coimbatore Medical College Hospital, K.M. Cherian Heart Foundation, Chettinad Health City Hospital, Rohini Hospital Tanjavoure and K.G. Hospital in Coimbatore. In the coming year Vasomeditech is planning to initiate additional programs through the PPP in private and public hospitals across the country.